The microbial detection array for detection of emerging viruses in clinical samples--a useful panmicrobial diagnostic tool.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24963710.
- Also identified by DOI 10.1371/journal.pone.0100813 and PMC identifier 4070998.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Emerging viruses are usually endemic to tropical and sub-tropical regions of the world, but increased global travel, climate change and changes in lifestyle are believed to contribute to the spread of these viruses into new regions. Many of these viruses cause similar disease symptoms as other emerging viruses or common infections, making these unexpected pathogens difficult to diagnose. Broad-spectrum pathogen detection microarrays containing probes for all sequenced viruses and bacteria can provide rapid identification of viruses, guiding decisions about treatment and appropriate case management. We report a modified Whole Transcriptome Amplification (WTA) method that increases unbiased amplification, particular of RNA viruses. Using this modified WTA method, we tested the specificity and sensitivity of the Lawrence Livermore Microbial Detection Array (LLMDA) against a wide range of emerging viruses present in both non-clinical and clinical samples using two different microarray data analysis methods.
Medical subject headings
- Molecular Diagnostic Techniques
- Oligonucleotide Array Sequence Analysis
- RNA Virus Infections
- RNA Viruses